Ultragenyx Reports Fourth Quarter and Full-Year 2014 Financial Results and Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Ultragenyx Reports Fourth Quarter and Full-Year 2014 Financial Results and Corporate Update

Ultragenyx Pharma (RARE) Tops Q4 EPS by 1c

March 25, 2015 4:06 PM EDT

Ultragenyx Pharma (NASDAQ: RARE) reported Q4 EPS of ($0.52), $0.01 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.

... More